ProShare Advisors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,334
| Closed | -$186K | – | 2289 |
|
|
2024
Q4 | $186K | Buy |
19,334
+6,362
| +49% | +$61.1K | ﹤0.01% | 1906 |
|
|
2024
Q3 | $37.1K | Buy |
+12,972
| New | +$37.1K | ﹤0.01% | 2009 |
|
|
2024
Q2 | – | Sell |
-12,210
| Closed | -$39K | – | 2029 |
|
|
2024
Q1 | $39K | Buy |
12,210
+960
| +9% | +$3.06K | ﹤0.01% | 1935 |
|
|
2023
Q4 | $37.8K | Sell |
11,250
-3,262
| -22% | -$11K | ﹤0.01% | 1885 |
|
|
2023
Q3 | $34.5K | Buy |
14,512
+58
| +0.4% | +$138 | ﹤0.01% | 1750 |
|
|
2023
Q2 | $25.4K | Buy |
+14,454
| New | +$25.4K | ﹤0.01% | 1825 |
|
|
2022
Q2 | – | Sell |
-11,861
| Closed | -$53K | – | 2182 |
|
|
2022
Q1 | $53K | Sell |
11,861
-3,223
| -21% | -$14.4K | ﹤0.01% | 2111 |
|
|
2021
Q4 | $103K | Sell |
15,084
-1,918
| -11% | -$13.1K | ﹤0.01% | 2201 |
|
|
2021
Q3 | $124K | Sell |
17,002
-1,628
| -9% | -$11.9K | ﹤0.01% | 1882 |
|
|
2021
Q2 | $187K | Buy |
18,630
+1,196
| +7% | +$12K | ﹤0.01% | 2163 |
|
|
2021
Q1 | $166K | Buy |
17,434
+4,918
| +39% | +$46.8K | ﹤0.01% | 2082 |
|
|
2020
Q4 | $137K | Buy |
+12,516
| New | +$137K | ﹤0.01% | 1940 |
|